Covishield Current Affairs, GK & News
Bharat Biotech Nasal Booster Trials
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the strength to fight against the third wave that is violently spreading the Omicron. About the ..
Month: Current Affairs - January, 2022
Category: Economy & Banking Current Affairs - 2022 • Science & Technology Current Affairs
Topics: Bharat Biotech • booster dose • Clinical trial • COVAXIN • COVID-19 vaccination • COVID-19 vaccine • Covishield • Drug Controller General of India • Intranasal vaccine
Conditional market approval for Covaxin, Covishield
The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional market authorisation? The Serum Institute vaccine COVISHELD and Bharat Biotech’s COVAXIN were administered in the ..
Month: Current Affairs - January, 2022
Category: Economy & Banking Current Affairs - 2022
Topics: AstraZeneca • Bharat Biotech • conditional market authorisation • COVAXIN • COVID 19 pandemic • Covishield • Drugs and Cosmetics Act 1940 • Emergency Use Authorisation • European Union (EU) • mRNA vaccine • Pfizer • Serum Institute of India (SII) • USFDA
Precautionary vaccine jabs in India
The Government of India is to provide third dose of vaccine. This third dose has been named “precaution dose” or booster dose. About the precaution dose The health care workers, comorbid patients (people with severe medical conditions) and frontline workers are eligible to get the precaution dose. Five states in the country are to go ..
Month: Current Affairs - January, 2022
Category: Science & Technology Current Affairs
Topics: 2-DG • Biological E • booster dose • Cadila Pharmaceuticals • Cipla • Convax • Corbevax • COVAXIN • COVID-19 vaccines • Covishield • Covovax Vaccine • COWIN • Johnson and Johnson • Moderna • Molnupiravir • mRNA vaccine • precaution dose • Tocilizumab • ZyCov-D • Zydus Cadila
WHO’s medical alert on fake Covishield Vaccines
World Health Organisation (WHO) issued medical alerts on fake Covishield Vaccines in India. Key Points WHO has raised doubts on the genuineness of Covishield which is reaching patients in India. India is reporting circulation of fake vials of the covid-19 vaccine that has been developed by Oxford-AstraZeneca while manufactured by Serum Institute of India (SII). ..
Month: Current Affairs - August, 2021
Category: India Nation & States Current Affairs • Science & Technology Current Affairs
Topics: COVID-19 vaccine • Covishield • CoWIN Platform • Fake covishield vaccine • Serum Institute of India (SII)
Cyrus Poonawala to receive Lokmanya Tilak Award
The founder of the Serum Institute of India (SII) in Pune, businessman Cyrus Poonawalla has been named the winner of the prestigious National Lokmanya Tilak Award 2021. Highlights He will be commended for his work during the COVID-19 pandemic and how his company helped save many lives by creating the Covishield vaccine and then making ..
Month: Current Affairs - July, 2021
Category: Awards, Persons & Places in News
Topics: COVID 19 pandemic • Covishield • Cyrus Poonawalla • National Lokmanya Tilak Award 2021 • Serum Institute of India (SII)
ZyCoV-D: World’s first DNA-based Vaccine
Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the world’s first DNA-based vaccine. With this, the number of vaccines available in the country will increase to 4. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin and ..
Month: Current Affairs - June, 2021
Category: Science & Technology Current Affairs
Topics: Coronavirus • COVAXIN • COVID-19 • COVID-19 vaccine • Covishield • SPUTNIK V • ZyCov-D